Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: Patient outcomes, incidence of appropriate and inappropriate interventions, and complications
Circulation. Arrhythmia and Electrophysiology , Volume 6 - Issue 3 p. 562- 568
Background-Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is a cardiomyopathy characterized by ventricular arrhythmias and an abnormal right ventricle. Implantable cardioverter defibrillator (ICD) therapy may prevent sudden cardiac death in patients with ARVD/C. Currently, an overview of outcomes, appropriate and inappropriate interventions, and complications of ICD therapy in ARVD/C is lacking. Methods and Results-A literature search was performed to identify studies reporting outcome and complications in patients with ARVD/C who underwent ICD implantation. Of 641 articles screened, 24 studies on 18 cohorts were eligible for inclusion. In case of multiple publications on a cohort, the most recent publication was included in the meta-analysis. There were 610 patients (mean age, 40.4 years; 42% women), who had an ICD for primary or secondary prevention of sudden cardiac death. Risk factors for sudden cardiac death were presyncope (61%), syncope (31%), previous cardiac arrest (14%), ventricular tachycardia (58%), and ventricular fibrillation (6%). Antiarrhythmic medication consisted mostly of β-blockers (38%), amiodarone (14%), or sotalol (30%). During the 3.8-year follow-up, annualized cardiac mortality rate was 0.9%, annualized noncardiac mortality rate was 0.8%, and annualized heart transplant rate was 0.9%. The annualized appropriate and inappropriate ICD intervention rates were 9.5% and 3.7%, respectively. ICD-related complications consisted of difficult lead placement (18.4%), lead malfunction (9.8%), infection (1.4%), lead displacement (3.3%), and any complication (20.3%). Conclusions-Cardiac and noncardiac mortality rates after ICD implantation in patients with ARVD/C are low. Appropriate ICD interventions occur at a rate of 9.5%/y. Inappropriate ICD interventions and complications lead to considerable ICDrelated morbidity.
|Arrhythmogenic right ventricular dysplasia/cardiomyopathy, Complication, Implantable cardioverter defibrillator, Prognosis, Sudden cardiac death|
|Circulation. Arrhythmia and Electrophysiology|
|Organisation||Department of Cardiology|
Schinkel, A.F.L. (2013). Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: Patient outcomes, incidence of appropriate and inappropriate interventions, and complications. Circulation. Arrhythmia and Electrophysiology, 6(3), 562–568. doi:10.1161/CIRCEP.113.000392